Psyence Biomedical (PBM) Stock Chart & Stock Price History $1.91 -0.01 (-0.52%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Psyence Biomedical Stock Price Performance 5 Day Performance-8.17%1 Month Performance-19.41%3 Month Performance-75.97%6 Month Performance-91.25%Year-To-Date Performance-9.48% Receive PBM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Psyence Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address Despite the Tesla Crash, These Traders Are 9 for 9 (Ad)Most Tesla shareholders are disappointed in the stock's performance in 2024, with a 30% decline year to date. But not this guy… One trader has found a way to turn Tesla’s downfall into a flurry of opportunity. In fact, he hasn’t lost a single trade on Tesla this year! See for yourself (Notice how short of a time period he holds onto the stock):*Get Access To the Free Training Here!* PBM Stock Chart for Tuesday, January, 7, 2025 PBM Chart by TradingView Psyence Biomedical Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/07/2025$1.92$1.91-0.52%$2.04$1.91121,023 shs$1.61 million01/06/2025$2.02$1.92-4.95%$2.07$1.91208,011 shs$1.62 million01/03/2025$2.08$2.02-2.88%$2.20$1.99216,028 shs$1.70 million01/02/2025$2.11$2.08-1.42%$2.27$2.06183,415 shs$1.75 million01/01/2025$2.11$2.11$2.31$2.08275,219 shs$1.78 million12/31/2024$2.13$2.11-0.94%$2.31$2.08275,219 shs$1.78 million Get the Latest News and Ratings for PBM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Psyence Biomedical and its competitors with MarketBeat's FREE daily newsletter. 12/30/2024$2.26$2.13-5.75%$2.31$2.08265,625 shs$1.80 million12/27/2024$2.39$2.26-5.44%$2.38$2.18307,399 shs$1.91 million12/26/2024$2.43$2.39-1.65%$2.54$2.07625,143 shs$2.02 million12/25/2024$2.43$2.43$2.45$2.20422,534 shs$2.05 million12/24/2024$2.38$2.43+2.10%$2.45$2.20422,534 shs$2.05 million12/23/2024$3.18$2.38-25.16%$2.65$2.091.58 million shs$2.01 million12/20/2024$2.46$3.18+29.27%$4.25$2.7823.98 million shs$2.68 million12/19/2024$1.53$2.46+60.78%$7.87$1.8175.16 million shs$2.07 million12/18/2024$1.75$1.53-12.57%$1.78$1.51254,775 shs$1.29 million12/17/2024$1.85$1.75-5.41%$1.82$1.67297,895 shs$1.48 million12/16/2024$1.85$1.85$1.93$1.81120,049 shs$1.56 million12/13/2024$2.04$1.85-9.31%$2.11$1.82277,183 shs$1.55 million12/12/2024$2.07$2.04-1.45%$2.05$1.97243,149 shs$1.72 million12/11/2024$2.07$2.07$2.18$1.85696,408 shs$1.74 million12/10/2024$2.07$2.07$2.84$2.0317.35 million shs$1.74 million12/09/2024$2.37$2.07-12.66%$2.17$1.80479,642 shs$1.74 million12/06/2024$2.64$2.37-10.23%$3.00$2.131.38 million shs$1.99 million Related Companies GRI Bio Stock Price Chart Evoke Pharma Stock Price Chart Aptorum Group Stock Price Chart GT Biopharma Stock Price Chart Trinity Biotech Stock Price Chart Syros Pharmaceuticals Stock Price Chart Virax Biolabs Group Stock Price Chart Adial Pharmaceuticals Stock Price Chart Alzamend Neuro Stock Price Chart CNS Pharmaceuticals Stock Price Chart Receive PBM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Psyence Biomedical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PBM) was last updated on 1/7/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
